Brain-targeting delivery of MMB4 DMS using carrier-free nanomedicine CRT-MMB4@MDZ
Brain-targeting delivery of 1,1'-methylenebis[4-[(hydroxyimino)methyl]-pyridinium] dimethanesulfonate (MMB4 DMS) is limited by its hydrophilic property and chemical instability. In order to solve this problem, herein, we develop a facile protocol through combining antisolvent precipitation and...
Furkejuvvon:
Váldodahkkit: | Yimeng Du (Dahkki), Jing Gao (Dahkki), Hui Zhang (Dahkki), Xiaohui Meng (Dahkki), Dong Qiu (Dahkki), Xiang Gao (Dahkki), Aiping Zheng (Dahkki) |
---|---|
Materiálatiipa: | Girji |
Almmustuhtton: |
Taylor & Francis Group,
2021-01-01T00:00:00Z.
|
Fáttát: | |
Liŋkkat: | Connect to this object online. |
Fáddágilkorat: |
Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|
Geahča maid
-
Malignant myoepithelioma of the breast (MMB); An interesting case report with pathological, immunohistochemical findings and review of literature
Dahkki: Ola A. Harb, et al.
Almmustuhtton: (2019) -
Size, shape, charge and "stealthy" surface: Carrier properties affect the drug circulation time in vivo
Dahkki: Jinwei Di, et al.
Almmustuhtton: (2021) -
DMS est en deuil...
Almmustuhtton: (2018) -
Aux collaborateurs de DMS
Dahkki: Martine Vidal, et al.
Almmustuhtton: (2013) -
Smart stimuli-responsive carrier-free nanoassembly of SN38 prodrug as efficient chemotherapeutic nanomedicine
Dahkki: Guanting Li, et al.
Almmustuhtton: (2023)